Dianthus Therapeutics Inc.
DNTH | NASDAQ
$98.31
+$1.84 (+1.91%)
Sep 22, 2026, 12:40 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -9.81 | -8.55 | -1.23 | -0.83 | -18.55 | -4.59 |
PEG Ratio | -0.15 | 0.12 | -0.11 | -0.01 | 0.22 | 0.26 |
PS Ratio | 764.98 | 116.48 | 18.97 | 3.69 | 164.92 | n/a |
PB Ratio | 3.16 | 2.06 | 0.32 | 0.32 | 1.41 | 2.39 |
P/FCF Ratio | -12.05 | -9.28 | -1.45 | -0.81 | -4 | -5.34 |
P/OCF Ratio | -12.07 | -9.29 | -1.45 | -0.81 | -4.09 | -5.38 |
OCF/S Ratio | -6.34K | -1.25K | -1.3K | -453.02 | -4.03K | n/a |
Debt / Equity Ratio | 0 | 0 | 0 | 0.01 | n/a | n/a |
Quick Ratio | 13.32 | 15.22 | 18.42 | 9.97 | 16.63 | 13.26 |
Current Ratio | 13.32 | 15.22 | 18.42 | 9.97 | 16.63 | 13.26 |
Asset Turnover | 0 | 0.02 | 0.02 | 0.08 | 0.01 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -20.90 |
Return on Equity | -32.90% | -24.11% | -25.79% | -38.66% | -7.59% | -52.07% |
Return on Assets | -30.58% | -22.72% | -24.28% | -34.26% | -6.90% | -46.37% |
Return on Invested Capital | -35.55% | -28.62% | -28.31% | -39.48% | -7.31% | -52.40% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 100% | 100% | n/a |
Net Profit Margin | -7.97K% | -1.36K% | -1.54K% | -443.76% | -888.14% | n/a |
Pretax Profit Margin | -7.97K% | -1.36K% | -1.54K% | -443.76% | -888.14% | n/a |
Operating Profit Margin | -8.74K% | -1.63K% | -1.7K% | -462.91% | -886.59% | n/a |
FCF Margin | -6.35K% | -1.26K% | -1.31K% | -455.18% | -4.12K% | n/a |
EBITDA Margin | -7.95K% | -1.36K% | -1.53K% | -441.47% | -751.29% | n/a |
Add to Watchlist
Select watchlists to add or remove DNTH